Inventor
AISSAOUI HAMED
CH38 patents
⚠️ This page may combine multiple inventors who share the name “AISSAOUI HAMED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACTELION PHARMACEUTICALS LTD
16 patentsUS7994336B2Aug 9, 2011
Azetidine compounds as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD23 citations92
US7763638B2Jul 27, 2010
Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
ACTELION PHARMACEUTICALS LTD24 citations92
US8003654B2Aug 23, 2011
N-glycinsulfonamide derivatives and uses as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD7 citations84
US7834028B2Nov 16, 2010
Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD9 citations84
US7435815B2Oct 14, 2008
Sulfonylamino-acetic acid derivatives
ACTELION PHARMACEUTICALS LTD10 citations84
US7279578B2Oct 9, 2007
Sulfonylamino-acetic acid derivatives
ACTELION PHARMACEUTICALS LTD11 citations84
US7192950B2Mar 20, 2007
Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD15 citations84
US6703392B2Mar 9, 2004
1,2,3,4-tetrahydroisoquinoline derivatives
ACTELION PHARMACEUTICALS LTD20 citations81
US7538109B2May 26, 2009
Quinoxalin-3-one derivatives as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD7 citations74
US7375227B2May 20, 2008
Quinoline derivatives
ACTELION PHARMACEUTICALS LTD2 citations62
US6815451B2Nov 9, 2004
1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
ACTELION PHARMACEUTICALS LTD2 citations62
US11136317B2Oct 5, 2021
NADPH oxidase 4 inhibitors
ACTELION PHARMACEUTICALS LTD0 citations60
US10584118B2Mar 10, 2020
NADPH oxidase 4 inhibitors
ACTELION PHARMACEUTICALS LTD0 citations50
US9255090B2Feb 9, 2016
Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
ACTELION PHARMACEUTICALS LTD0 citations41
US9169270B2Oct 27, 2015
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
ACTELION PHARMACEUTICALS LTD0 citations41
US9637473B2May 2, 2017
Acrylamide derivatives as antimalarial agents
ACTELION PHARMACEUTICALS LTD0 citations36
AISSAOUI HAMED
16 patentsUS8288411B2Oct 16, 2012
Pyrrolidines and piperidines as orexin receptor antagonists
AISSAOUI HAMED14 citations84
US8236964B2Aug 7, 2012
Thiazolidine derivatives as orexin receptor antagonists
AISSAOUI HAMED13 citations84
US8106215B2Jan 31, 2012
3-aza-bicyclo[3.3.0]octane compounds
AISSAOUI HAMED13 citations84
US8288435B2Oct 16, 2012
2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
AISSAOUI HAMED11 citations83
US8288429B2Oct 16, 2012
2-aza-bicyclo[3.3.0]octane derivatives
AISSAOUI HAMED15 citations83
US8063099B2Nov 22, 2011
Trans-3-aza-bicyclo[3.1.0]hexane derivatives
AISSAOUI HAMED7 citations82
US8188082B2May 29, 2012
5,6,7,8-tetrahydro-imidazo[1,5-α]pyrazine derivatives
AISSAOUI HAMED8 citations78
US9242970B2Jan 26, 2016
Lactam derivatives useful as orexin receptor antagonists
AISSAOUI HAMED3 citations72
US8236801B2Aug 7, 2012
2-aza-bicyclo[2.2.1]heptane derivatives
AISSAOUI HAMED6 citations72
US8697869B2Apr 15, 2014
3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators
AISSAOUI HAMED6 citations71
US9096595B2Aug 4, 2015
7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators
AISSAOUI HAMED4 citations69
US8889688B2Nov 18, 2014
Piperazines as antimalarial agents
AISSAOUI HAMED2 citations62
US8133901B2Mar 13, 2012
3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
AISSAOUI HAMED4 citations62
US8575158B2Nov 5, 2013
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
AISSAOUI HAMED2 citations60
US8329706B2Dec 11, 2012
Oxazolidinone derivatives
AISSAOUI HAMED1 citations51
US7067519B2Jun 27, 2006
7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
AISSAOUI HAMED0 citations41
IDORSIA PHARMACEUTICALS LTD
6 patentsUS9879006B2Jan 30, 2018
Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations70
US11306078B2Apr 19, 2022
Piperidine CXCR7 receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations57
US10351560B2Jul 16, 2019
Crystalline forms
IDORSIA PHARMACEUTICALS LTD0 citations49
US10301309B2May 28, 2019
Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations49
US9850241B2Dec 26, 2017
Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
IDORSIA PHARMACEUTICALS LTD1 citations49
US10752620B2Aug 25, 2020
Piperdine CXCR7 receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations47